What is NRXBF?
, a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 43.23M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.